JP5238532B2 - Medical multi-chamber container, method for recognizing drug mixture using the same, and multi-chamber container for medical use - Google Patents

Description

  The present invention relates to a medical multi-chamber container, a method for recognizing drug mixing using the same, and a medical multi-chamber container containing a medicine.

  Multiple drugs may be mixed and administered to patients, such as by dissolving or diluting antibiotics and vitamins in physiological saline, etc., mixing amino acid and glucose infusions, and injecting or instilling into patients. It has been broken. When mixing a plurality of medicines, some kinds of medicines may be altered by mixing them in advance. Conventionally, when combining drugs that may be altered, another drug is injected into the glass container immediately before use with a syringe or the like and mixed. However, in such a mixing operation, there has been a risk of causing a human error such as a mistake in the mixing ratio or forgetting to mix. In addition, in such a mixing operation, it is necessary to give due consideration to hygiene. However, a hygiene problem may occur due to an operation error. Furthermore, due to the complexity of work, there is a risk of causing medical errors such as mistaking the patient to be administered.

As a technique for avoiding a mistake in mixing the above-described medicines, a system that blends two or more kinds of medicines based on an inputted prescription is disclosed (for example, Patent Document 1). However, in cases where urgency is required, it is necessary to accurately mix the drugs by a simple method.
Therefore, in response to such a request, the container main body is partitioned by a weak seal portion to provide a plurality of medicine storage chambers, each medicine is stored in the medicine storage chamber without mixing, and the medicine storage chamber is externally used when used. A medical multi-chamber container is shown in which a weak seal portion that partitions a medicine storage chamber is peeled and opened to mix a medicine by applying pressure from the container (for example, Patent Document 2). By using such a medical multi-chamber container, two or more kinds of drugs can be hygienically mixed at an accurate mixing rate.

  When the medical multi-chamber container as described above is used, the work of mixing a plurality of drugs can be simplified, but confirmation of mixing of drugs must be relied upon visually. For this reason, there is a risk of forgetting to open and peel the weak seal portion. In addition, transparent packaging materials are often used for infusion containers used for medical purposes so that the contents can be visually confirmed. For this reason, there exists a problem that it is difficult to confirm the peeling opening of a weak seal part.

  For such problems, a part of the container body is fixed in a bent state by a fixing member, and the weak seal portion is peeled open by increasing the pressure of the medicine storage chamber, and the weak seal portion is peeled off by releasing the bent state. A medical multi-chamber container that can be easily confirmed to be opened is shown (for example, Patent Document 3). Also, an RFID (Radio) is provided that includes a break opening portion that separates a plurality of spaces and is opened by breakage by an external force, and allows medical materials to move between the spaces, and is disposed in the vicinity of the break opening portion. Frequency identification) shows a medical multi-chamber container that is broken so as not to communicate when the break opens (for example, Patent Document 4). The medical multi-chamber container of Patent Document 4 can detect the confirmation of break opening that relies on visual observation by disabling RFID communication.

JP-T-2007-515213 JP 2003-111818 A JP 2007-282707 A JP 2007-267869 A

  However, since the medical multi-chamber container of Patent Document 4 uses a complicated mechanism for providing RFID by a break opening portion, the manufacturing process is complicated and the cost is increased. In addition, after confirming mixing of medicines by destruction of the RFID due to break opening, the RFID cannot be used again. In medical practice, it is also important to confirm the accuracy of medical practices, such as ensuring that the necessary drugs are administered to individual patients. System is desired.

  Therefore, in the present invention, a medical multi-chamber container that can easily and accurately confirm the accuracy of mixing of medicines and medical practices and can be manufactured at a low cost by a simple method, and the medical multi-chamber container are used. It is an object of the present invention to provide a method for recognizing a drug mixture and a medical multi-chamber container containing the drug.

In order to achieve the above object, the present invention employs the following configuration.
[1] It has a transparent transparent container main body, and the container main body is partitioned into two or more medicine storage chambers by a peelable weak seal portion, and a barcode is provided on one side of the weak seal portion. A multi-chamber container for medical use in which a barcode reading inhibiting portion that prevents reading of the barcode is provided in a portion corresponding to the barcode on the other side of the weak seal portion.
[2] The medical multi-chamber container according to [1], wherein the flexible container body is made of a flexible film.
[3] A method for recognizing drug mixing using the medical multi-chamber container according to [1] or [2] containing two or more kinds of drugs, wherein the weak seal portion is in a sealed state, The weak seal portion is peeled off by mixing the two or more kinds of chemicals by separating the weak seal portion, separating the barcode and the barcode reading inhibiting portion, and then reading the barcode. Recognizing a drug mixture.
[4] A medical-equipped medical multi-chamber container in which a medicine is contained in the medical multi-chamber container according to [1] or [2].

  According to the medical multi-chamber container of the present invention, the method for recognizing drug mixing using the medical multi-chamber container, and the medical multi-chamber container containing the drug, mixing of the drug and confirmation of the accuracy of the medical practice can be performed. It can be done easily and accurately. Moreover, the medical multi-chamber container of the present invention and the medical multi-chamber container containing a medicine can be manufactured inexpensively by a simple method.

It is the perspective view which showed an example of embodiment of the medical multiple chamber container of this invention. It is II-II sectional drawing of the medical multiple-chamber container of FIG. (A), (B) It is the top view which showed the barcode of this invention, and the barcode reading inhibition part. (C), (D) It is process drawing of recognition of the chemical | medical solution mixing of this invention. It is sectional drawing which shows the state which peeled the weak seal part of the medical multiple-chamber container of FIG. It is the schematic which showed an example of a mode that the barcode of the medical multiple chamber container of this invention was read with a barcode reader.

(Medical multi-chamber container)
An example of the embodiment of the medical multi-chamber container of the present invention will be described with reference to FIGS.
As shown in FIG. 1, the medical multi-chamber container 10 includes a rectangular container body 20 in which a flexible film 11 and a flexible film 12 are fused so that a peripheral edge thereof cannot be peeled off. The container body 20 has flexibility. Further, the container body 20 is provided with a weak seal portion 26 in which the flexible film 11 and the flexible film 12 are detachably sealed so as to be linear in the short direction of the container body 20, and the weak seal is provided. The container body 20 is partitioned into a first drug storage chamber 22 and a second drug storage chamber 24 by the portion 26. The first drug storage chamber 22 and the second drug storage chamber 24 are arranged side by side in the longitudinal direction of the container body 20.

  On the lower end 15 side of the container body 20, a resin hollow discharge port 14 sandwiched between the flexible film 11 and the flexible film 12 is provided. The discharge port 14 is closed with a rubber plug (not shown) at the time of transportation and storage, and has a configuration in which a puncture needle can be inserted during use. In addition, a protective film (not shown) that covers the surface through which the puncture needle can be inserted is detachably provided at the discharge port 14. The discharge port 14 and the second drug storage chamber 24 communicate with each other, and the discharge of the drug is prevented by the discharge port 14. Further, a circular hanging hole 16 is provided at the peripheral edge on the upper end portion 13 side.

A bar code 30 is attached to the flexible seal 11 side of the weak seal portion 26 (FIGS. 1 and 2). Further, a bar code reading inhibiting unit 40 (hereinafter referred to as “inhibiting unit 40”) that prevents the bar code 30 from being read is provided at a portion corresponding to the bar code 30 on the flexible film 12 side of the weak seal portion 26. (FIG. 2).
The flexible film 11 is a synthetic resin used in the field of medical containers and is made of a transparent material. The transparency in the present invention is not limited as long as the contents can be visually recognized, and the light transmittance in water at a wavelength of 450 nm is preferably 55% or more.
Examples of the synthetic resin used for the flexible film 11 include polyolefin resin, polyamide resin, polyester resin, (meth) acrylic resin, vinyl chloride resin, vinylidene chloride resin, polyethersulfone, and ethylene-vinyl alcohol copolymer. Etc. Of these, polyolefin resins are preferred from the viewpoints of excellent transparency, flexibility and hygiene, and low cost.

Examples of the polyolefin resin include high-density polyethylene, medium-density polyethylene, high-pressure low-density polyethylene, linear low-density polyethylene, polyethylene-based resins such as ethylene-vinyl acetate copolymer, and ethylene-α olefin random copolymer. Olefin-based elastomers, polypropylene, ethylene-propylene random copolymers, polypropylene resins such as α-olefin-propylene random copolymers, cyclic polyolefin resins, and the like, and mixtures thereof. Such a resin may be partially crosslinked for the purpose of improving heat resistance.
The flexible film 11 may be a single layer film or a multilayer film.

The thickness of the flexible film 11 is preferably 50 to 1000 μm, and more preferably 100 to 500 μm.
A film having a metal such as an aluminum foil or an aluminum foil laminate for light shielding and barrier purposes as long as it does not contradict the purpose of the present invention, such as peeling from the flexible film 11 when the medical multi-chamber container 10 is used. May be provided outside the flexible film 11.

  The flexible film 12 can use the same thing as the thing quoted by the flexible film 11, and a preferable aspect is also the same.

The bar code 30 (FIG. 3A) may be any code that can read and recognize the described information by a reading means such as a bar code reader. For example, a bar code such as a JAN code or RSS code, a QR code, etc. These two-dimensional barcodes are listed. The size of the barcode 30 is not particularly limited as long as it is a prescribed size, and may be appropriately selected according to the reading means used.
Further, the barcode 30 is positioned such that when the weak seal portion 26 is peeled off and the flexible film 11 and the flexible film 12 of the weak seal portion 26 are separated from each other, the barcode 30 and the inhibition portion 40 are sufficient. It is sufficient if it is a position away from each other, and it is preferable that it is the central portion in the short direction of the container body 20 in the weak seal portion 26.

Moreover, although the barcode 30 showed the example given to the surface of the flexible film 11 in FIG.3 and FIG.4, when the flexible film 11 is a laminated | multilayer film, it is an interlayer of each layer of this laminated film It may be given to.
The color of the bar portion of the bar coat 30 is preferably a color that hardly reflects the light emitted from the barcode reader. Among them, when the bar portion of the barcode 30 is the same color as the color of the irradiated light, the color of the bar portion is reflected and cannot be read. Therefore, colors other than the similar colors of the irradiated light are preferable. For example, red laser light is often used as the light source of the irradiation light of the barcode reader. In this case, if the bar portion of the barcode 30 is red, the color of the bar portion of the barcode 30 with respect to the irradiation light. Is reflected, it is impossible to read the barcode 30, which is not preferable.
Examples of the information described in the barcode 30 include identification information for identifying the medical multi-chamber container 10.

The inhibition unit 40 (FIG. 3B) is located in a portion corresponding to the barcode 30 in the flexible film 12 of the weak seal portion 26, and prevents reading of the barcode 30 by reading means such as a barcode reader. It is something that can be done. Since the flexible film 11 in the present invention is transparent, the portion of the barcode 30 in the weak seal portion 26 can be seen through from the flexible film 11 side to the flexible film 12. Therefore, in the medical multi-chamber container 10, if the barcode 30 is read without the weak seal portion 26 being peeled off, the barcode 30 and the inhibition portion 40 are overlapped, so that the barcode 30 is read. It is hindered (FIG. 3C). On the other hand, when the weak seal portion 26 is peeled and the chemical solution is mixed, the flexible film 11 and the flexible film 12 that are weakly sealed in the weak seal portion 26 are separated from each other, and the barcode 30 is accordingly accompanied. Since the inhibition part 40 is separated, the barcode 30 can be read without being obstructed by the inhibition part 40 (FIG. 3D).
In particular, when the mixed medicine is a white color such as a fat emulsion, the irradiation light is easily reflected from the space portion of the barcode 30, so that the barcode 30 can be easily read.

The color of the inhibition unit 40 is not limited as long as it can prevent reading of the barcode 30, and it is easy to make it difficult to recognize the difference in the reflectance of the irradiated light of the barcode reader or the like of the barcode portion of the barcode 30 and the space portion. The color is preferably the same color as the bar portion of the cord 30, more preferably the same color, and particularly preferably the same color when viewed through the weak seal portion 26. For example, when the bar portion of the barcode 30 is black, it is particularly preferable that the color of the inhibition portion 40 is black. However, even when the color is dark green, dark blue, etc., reading of the barcode 30 can be hindered. . The color of the inhibition unit 40 may be one color or two or more colors.
Further, when the space portion of the barcode 30 is colored and the bar portion is colorless and transparent, the inhibition portion 40 may be the same color or the same color as the space portion of the barcode 30.
Moreover, the shape of the inhibition part 40 should just be able to prevent reading of the barcode 30, for example, a rectangular shape (FIG. 3 (B)), a circular shape, an elliptical shape, etc., and arbitrary patterns and characters are drawn. It may be.
Moreover, the inhibition part 40 may have a metal surface or a mirror surface, and the metal surface or the mirror surface may be reproduced by printing or the like. Since these are glossy, there is a possibility that the irradiation light from the barcode reader or the like causes specular reflection by the blocking unit 40 and returns very strong reflected light, which exceeds the intensity that can be received by the barcode reader or the like. is there. Therefore, it becomes easy to inhibit reading of the barcode 30 with a barcode reader etc. by superimposing such an inhibition part 40 on the barcode 30.
3 and 4 show an example in which the inhibiting portion 40 is provided on the surface of the flexible film 12, but when the flexible film 12 is a laminated film, the layers between the layers of the laminated film are shown. It may be given to.

  The size of the inhibition portion 40 may be any size that prevents the barcode 30 from being read in a state where the weak seal portion 26 is sealed, and is determined in consideration of the type and size of the barcode 30. Can do. The size of the blocking portion 40 may be the same size as the barcode 30, or may be formed to a portion other than the portion corresponding to the barcode 30, and the flexible film 12 in the weak seal portion 26. It may be throughout. Further, the barcode 30 may be of a size that cannot be partially recognized (for example, the right half). The size of the inhibition portion 40 is the same as that of the barcode 30 in that the weak seal portion 26 can be surely confirmed whether it is visually observed or the barcode 30 is read by a barcode reader. It is preferable that the size is equal to or greater than that.

Reading means such as a barcode reader that reads the barcode 30 preferably irradiates the surface of the barcode 30 with the irradiation light inclined. When the irradiated light is irradiated to the barcode 30 at a right angle, the light of the specularly reflected light from the space portion of the barcode 30 may be returned to the barcode reader or the like, and the light can be received. The strength may be exceeded. In this case, there is a possibility that the barcode 30 cannot be read even if the barcode 30 and the inhibition portion 40 are separated from each other. Accordingly, as shown in FIGS. 5A and 5B, the reading unit 100 is provided so that the irradiation light is inclined with respect to the surface of the barcode 30, and the irradiation light is inclined with respect to the barcode 30. It is preferable to irradiate and receive irregularly reflected light of the irradiated light. In this case, in a state where the weak seal portion 26 is sealed and the barcode 30 and the inhibition portion 40 overlap each other, the barcode 30 cannot be read (FIG. 5A), and the barcode 30 and the inhibition portion 40 are separated from each other. In this case, only irregularly reflected light is received for reading (FIG. 5B).
Further, as shown in FIGS. 5C and 5D, a portion having a high reflectance such as the white portion 50 is provided around the inhibition portion 40, and the irradiation light from the reading unit 100 is inclined with respect to the barcode 30. It is preferable that the irregularly reflected light of the irradiated light is received by irradiating. By providing a highly reflective portion such as the white portion 50, the barcode 30 cannot be read in a state where the weak seal portion 26 is sealed (FIG. 5C), while the weak seal portion 26 is separated. When this occurs (FIG. 5D), the amount of irregularly reflected light increases, making it easier to read the barcode 30.

(Medical multi-chamber container with drugs)
By filling the first medicine storage chamber 22 with the first medicine A and the second medicine storage chamber 24 with the second medicine B, a medical-equipped medical multi-chamber container is obtained.
The 1st chemical | medical agent A should just have fluidity | liquidity, and can mention chemical | medical agents, such as a liquid and a powder. The second drug B is the same as the first drug A. However, since the medical multi-chamber container 10 is often used to store a drug for infusion or a drug for injection, whether the first drug A or the second drug B is a liquid drug, Both the first drug A and the second drug B are liquid drugs.

  The filling amount of the first medicine A and the second medicine B can be determined according to the kind of the medicine. The capacity and shape of the medical multi-chamber container 10 can be determined in consideration of the degree of separation between the barcode 30 and the inhibition portion 40 when the weak seal portion 26 is peeled off. The degree of separation between the barcode 30 and the inhibition portion 40 when the weak seal portion 26 is peeled is particularly a distance that allows the barcode 30 to be read by a reading means such as a barcode reader without obstruction of the inhibition portion 40. Although not limited, for example, the separation distance between the barcode 30 and the inhibition portion 40 is preferably 5 mm or more.

(Production method)
The medical multi-chamber container 10 can be manufactured by the following manufacturing method, for example.
First, the flexible film 11 and the flexible film 12 are overlapped and fused by heat-sealing the peripheral edge on the side end 17 side. Next, a weak seal portion 26 is provided at a position partitioned into the first medicine storage chamber 22 and the second medicine storage chamber 24 with a peelable seal. The discharge port 14 is sandwiched between the flexible film 11 and the flexible film 12 so that the discharge port 14 is located at a desired position on the lower end portion 15 side, and the lower end portion 15 side is heat-sealed to be fused. .

  Next, the first medicine storage chamber 22 is filled with an arbitrary amount of the first medicine A from the upper end portion 13 side. Thereafter, the upper end 13 side is fused by heat sealing, and an arbitrary position on the fused upper end 13 side is drilled to provide the hanging hole 16. Next, for example, the second medicine B is filled into the second medicine storage chamber 24 from the discharge port 14, the discharge port 14 is closed with a rubber plug or the like, and the discharge port 14 is covered with a protective film so as to be peelable. Thus, the medical multi-chamber container 10 in which the first medicine A is filled in the first medicine storage chamber 22 and the second medicine B is filled in the second medicine storage chamber 24 can be obtained.

  As a method of forming the weak seal portion 26, for example, a synthetic resin film in which a layer made of a resin composition having a different melting point or compatibility, such as a mixture of polyethylene and polypropylene, is formed on the inner surface side of the container body 20 is used. A method of sealing at a temperature equal to or lower than the melting temperature of the resin having a melting point is mentioned. Alternatively, heat sealing is performed at a low temperature and weakly bonded in a semi-welded state, or a flexible material that has been previously cross-linked with an electron beam or the like is used for the formation portion of the weak seal portion 26, or a strong fusion portion is specified. Examples include a method of using a seal bar generated at an area ratio, or a method in which an easily peelable resin tape is sandwiched between the flexible film 11 and the flexible film 12.

The barcode 30 may be applied in advance to the flexible film 11 that forms the container body 20, and when applied to the surface of the flexible film 11, the barcode 30 may be applied after the weak seal portion 26 is formed. Good. Examples of the method for applying the barcode 30 include a method of printing a bar portion or a space portion by gravure printing or offset printing using ink, a method of printing by a hot stamp, a method of printing by an inkjet printer, and a barcode printing For example, a method of applying the transparent label, a method of creating a barcode by scraping off the solid printing portion with a laser or the like, and the like.
The inhibition part 40 may be formed in advance on the flexible film 12 that forms the container body 20, and when it is formed on the surface of the flexible film 12, it may be formed after the weak seal part 26 is formed. Good. As the formation method of the inhibition part 40, for example, a method of printing by gravure printing or offset printing using ink, a method of printing by hot stamp, a method of printing by an inkjet printer, a label on which the inhibition part is printed, etc. For example, a method of attaching a similar color resin tape or the like. Further, the inhibiting unit 40 may be any as long as the surface 40a overlapping the barcode 30 can inhibit the reading of the barcode 30, and other colors and designs may be given to the other surface 40b.
The medical multi-chamber container 10 can be obtained by the method as described above.

Moreover, the following method may be sufficient as the manufacturing method of the medical composite container 10. FIG.
First, the flexible film 11 and the flexible film 12 are overlapped and fused by heat-sealing the peripheral edge on the side end 17 side. The discharge port 14 is sandwiched between the flexible film 11 and the flexible film 12 so that the discharge port 14 is positioned at an arbitrary position on the lower end portion 15 side, and the lower end portion 15 side is heat-sealed to be fused. .
Thereafter, a weak seal portion 26 is provided at a position partitioned into the first drug storage chamber 22 and the second drug storage chamber 24 by performing a peelable seal. Next, the first medicine storage chamber 22 is filled with an arbitrary amount of the first medicine A from the upper end portion 13. The upper end portion 13 side is fused by heat sealing, and an arbitrary position on the fused upper end portion 13 side is drilled to provide a hanging hole 16. Next, the second medicine B is filled into the second medicine storage chamber 24 from the discharge port 14, the discharge port 14 is closed with a rubber plug or the like, and the discharge port 14 is covered with a protective film so as to be peelable.
The barcode 30 may be applied in advance to the flexible film 11 forming the container body 20 or may be applied after the weak seal portion 26 is formed. Further, the inhibition portion 40 may be formed in advance on the flexible film 12 that forms the container body 20 or may be formed after the weak seal portion 26 is formed.

(Drug recognition method)
A method for recognizing drug mixture using the medical multi-chamber container 10 of the present invention will be described.
First, the medical multi-chamber container 10 with the weak seal portion 26 sealed is prepared. At this time, the weak seal portion 26 is sealed, that is, the barcode 30 and the inhibition portion 40 are adjacently overlapped with each other via the weak seal portion 26, and the barcode 30 cannot be read. (FIG. 2 and FIG. 3C).
Next, when the first drug storage chamber 22 or the second drug storage chamber 24 of the medical multi-chamber container 10 is pressed from outside with an arbitrary pressure, the weak seal portion 26 is peeled off, and the first drug storage chamber 22 and the second drug storage chamber 22 are separated from each other. The medicine storage chamber 24 communicates, and the first medicine A and the second medicine B are mixed (FIG. 4).

  Moreover, when the weak seal part 26 peels, the barcode 30 by the side of the flexible film 11 and the inhibition part 40 by the side of the flexible film 12 will separate (FIG. 3 (D) and FIG. 4). When the barcode 30 and the inhibition unit 40 are separated from each other, the inhibition unit 40 is not obstructed, and the barcode 30 can be read and recognized by reading means such as a barcode reader. By reading the barcode 30 with the reading means, it is possible to recognize that the weak seal portion 26 is peeled off and the first medicine A and the second medicine B are mixed.

According to the medical multi-chamber container of the present invention, the barcode can be read by peeling off the weak seal portion. By reading the barcode, it is easy to mix the medicine without relying only on visual observation. And it can be confirmed reliably. In addition, even after the weak seal portion is peeled off, it can be recognized by reading the barcode that the medicine is mixed at any time, so that the accuracy of the medical practice can be surely confirmed. Specifically, for example, the following usage can be performed in conjunction with an electronic medical record system using a barcode.
In medical practice using an electronic medical chart system, when administering a drug to a patient, the information on the medical chart, the information on the barcode provided on the drug, and the information on the barcode identifying the patient are collated. Do. However, since the barcode provided in the medical multi-chamber container of the present invention cannot be read before mixing the drugs, such information cannot be collated before mixing the drugs.
Since the multi-chamber container for medical use of the present invention peels off the weak seal part and the barcode can be recognized only after the medicine is mixed, the collation of information using the electronic medical chart system is possible after the medicine is mixed. It becomes possible. That is, it is possible to reliably prevent a medical error in which a drug is administered to a patient without peeling off the weak seal portion and a medical error in which a drug is administered to a patient other than the patient to which the drug is originally administered. Become.
Further, the medical multi-chamber container of the present invention can be manufactured easily and inexpensively as compared with the medical multi-chamber container using the RFID of Patent Document 4.

The medical multi-chamber container of the present invention is not limited to the medical multi-chamber container illustrated in FIGS. For example, the weak seal portion 26 may be formed in a curved shape or an arc shape as long as the barcode 30 can be provided.
When a laminated film in which a metal film such as an aluminum foil is laminated on the flexible film 12 can be prevented from being read by the metal film, the metal film can be peeled off. Alternatively, the portion corresponding to the barcode 30 may be left on the flexible film 12 to form the inhibition portion 40.

  In addition, as a mode of determining the mixing operation of the medicine depending on whether the barcode can be read or not, the barcode can be read in a state where the weak seal portion is sealed. A form in which the barcode cannot be read when the seal portion is separated is also conceivable. However, the configuration in which the barcode 30 can be read only after the weak seal portion 26 is peeled off as in the case of the medical composite container 10, the first drug storage chamber 22, the second drug storage chamber 24, and the like. When is opened, the identification information and the like described in the barcode 30 can be read together with the opened information, which is preferable.

  As described above, the transparent and flexible container body has been described by exemplifying the medical multi-chamber container made of the flexible film. However, the container body 20 is not limited to the container body 20 having flexibility. For example, it may be formed by blow molding. Further, two or more weak seal portions of the medical multi-chamber container may be formed, and three or more medicine storage chambers may be provided. In this case, a bar code and a bar code reading inhibiting part may be provided in each weak seal part.

  In addition, the method for recognizing chemical liquid mixing according to the present invention is carried out by using an existing medical multi-chamber container that is not provided with a barcode and that has been provided with a barcode and formed a barcode reading inhibiting portion. Also good. In this case, since an existing multi-chamber container can be used, the present invention can be easily implemented at a medical site. In the case of three or more multidrug mixed drugs, a different barcode is applied to each weak seal part of a medical multi-chamber container partitioned into three or more drug storage chambers by two or more weak seal parts. Thus, it is possible to confirm that all the drugs are mixed accurately, which is effective in preventing medical errors.

  DESCRIPTION OF SYMBOLS 10 Medical multi-chamber container 11, 12 Flexible film 20 Container main body 22 1st chemical | medical agent storage chamber 24 2nd chemical | medical agent storage chamber 26 Weak seal part 30 Barcode 40 Barcode reading inhibition part

Claims (4)

A transparent container body having flexibility, and the container body is partitioned into two or more drug storage chambers by a weak seal portion that can be peeled;
A bar code is attached to one side of the weak seal part, and a bar code reading inhibiting part that prevents reading of the bar code is provided in a part corresponding to the bar code on the other side of the weak seal part. , Medical multi-chamber container.   The medical multi-chamber container according to claim 1, wherein the flexible container body is made of a flexible film. A method for recognizing drug mixing using the medical multi-chamber container according to claim 1 or 2 containing two or more kinds of drugs,
The weak seal portion is in a sealed state,
The two or more kinds of medicines are mixed by peeling off the weak seal portion, and after separating the barcode and the barcode reading inhibiting portion, the barcode is read to thereby remove the weak seal portion. A method for recognizing drug mixing that recognizes peeling.   A medical multi-chamber container containing a medicine, wherein the medicine is contained in the medical multi-chamber container according to claim 1.

Images